恶性肿瘤研究动态
@@ 血清超甲基化14-3-3-sigma及ESR1基因启动子作为转移性乳腺癌诊断及疗效评价的候选标记物”Zurita M,Lara PC,Del Moral R.et al.Hypermethylated 14-3-3-sigma and ESR1 gene promoters in serum as candidate biomarkers for the diagnosis and treatment efficacy of breast cancer metastasis”J”.BMC Cancer.2010 May 20;10(1):217.”Epub ahead of print””
肿瘤研究、treatment efficacy、cancer metastasis、乳腺癌诊断、基因启动子、疗效评价、超甲基化、转移性、标记物、血清
09
R45;S81
2010-12-08(万方平台首次上网日期,不代表论文的发表时间)
130-132